Uncertainty and patient heterogeneity in medical decision models.
作者： Bas Groot Koerkamp , Milton C. Weinstein , Theo Stijnen , M.H. Heijenbrok-Kal , M.G. Myriam Hunink
关键词:
摘要: … medical decision modeling, serving various stakeholders. Before the advent of cost-effectiveness analysis, the patient … myocardial infarction, his future mortality rate will increase. Markov …
sagepub.com
narcis.nl参考文章(54)
Andrew H. Briggs, David E. Wonderling, Christopher Z. Mooney, Pulling cost‐effectiveness analysis up by its bootstraps: A non‐parametric approach to confidence interval estimation Health Economics. ,vol. 6, pp. 327- 340 ,(1997) , 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W
Garry R. Barton, Andrew H. Briggs, Elisabeth A.L. Fenwick, Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI) Value in Health. ,vol. 11, pp. 886- 897 ,(2008) , 10.1111/J.1524-4733.2008.00358.X
Bas Groot Koerkamp, M.G. Myriam Hunink, Theo Stijnen, James K. Hammitt, Karen M. Kuntz, Milton C. Weinstein, Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis. Medical Decision Making. ,vol. 27, pp. 101- 111 ,(2007) , 10.1177/0272989X06297394
James C. Felli, Gordon B. Hazen, Sensitivity Analysis and the Expected Value of Perfect Information Medical Decision Making. ,vol. 18, pp. 95- 109 ,(1998) , 10.1177/0272989X9801800117
Gord Blackhouse, Ron Goeree, Bernie J. O’Brien, Andrew H. Briggs, Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Medical Decision Making. ,vol. 22, pp. 290- 308 ,(2002) , 10.1177/0272989X0202200408
Elisabeth Fenwick, Karl Claxton, Mark Sculpher, Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics. ,vol. 10, pp. 779- 787 ,(2001) , 10.1002/HEC.635
Aaron A. Stinnett, A. David Paltiel, Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means. Medical Decision Making. ,vol. 17, pp. 483- 489 ,(1997) , 10.1177/0272989X9701700414
A E Ades, S Cliffe, Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty Medical Decision Making. ,vol. 22, pp. 359- 371 ,(2002) , 10.1177/0272989X0202200414
AR Willan, EM Pinto, None, The value of information and optimal clinical trial design Statistics in Medicine. ,vol. 24, pp. 1791- 1806 ,(2005) , 10.1002/SIM.2069
Bas Groot Koerkamp, M. G. Myriam Hunink, Theo Stijnen, Milton C. Weinstein, Identifying key parameters in cost‐effectiveness analysis using value of information: a comparison of methods Health Economics. ,vol. 15, pp. 383- 392 ,(2006) , 10.1002/HEC.1064